Your browser doesn't support javascript.
loading
Screening for Primary Open-Angle Glaucoma: US Preventive Services Task Force Recommendation Statement.
Mangione, Carol M; Barry, Michael J; Nicholson, Wanda K; Cabana, Michael; Chelmow, David; Coker, Tumaini Rucker; Davis, Esa M; Donahue, Katrina E; Epling, John W; Jaén, Carlos Roberto; Krist, Alex H; Kubik, Martha; Li, Li; Ogedegbe, Gbenga; Pbert, Lori; Ruiz, John M; Simon, Melissa A; Stevermer, James; Wong, John B.
Afiliação
  • Mangione CM; University of California, Los Angeles.
  • Barry MJ; Harvard Medical School, Boston, Massachusetts.
  • Nicholson WK; University of North Carolina at Chapel Hill.
  • Cabana M; Albert Einstein College of Medicine, New York, New York.
  • Chelmow D; Virginia Commonwealth University, Richmond.
  • Coker TR; University of Washington, Seattle.
  • Davis EM; University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Donahue KE; University of North Carolina at Chapel Hill.
  • Epling JW; Virginia Tech Carilion School of Medicine, Roanoke.
  • Jaén CR; The University of Texas Health Science Center, San Antonio.
  • Krist AH; Virginia Commonwealth University, Richmond.
  • Kubik M; Fairfax Family Practice Residency, Fairfax, Virginia.
  • Li L; George Mason University, Fairfax, Virginia.
  • Ogedegbe G; University of Virginia, Charlottesville.
  • Pbert L; New York University, New York, New York.
  • Ruiz JM; University of Massachusetts Medical School, Worcester.
  • Simon MA; University of Arizona, Tucson.
  • Stevermer J; Northwestern University, Chicago, Illinois.
  • Wong JB; University of Missouri, Columbia.
JAMA ; 327(20): 1992-1997, 2022 05 24.
Article em En | MEDLINE | ID: mdl-35608574
ABSTRACT
Importance Glaucoma affects an estimated 2.7 million people in the US. It is the second-leading cause of irreversible blindness in the US and the leading cause of blindness in Black and Hispanic/Latino persons.

Objective:

To update its 2013 recommendation, the US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of screening for glaucoma in adults. Population Adults 40 years or older who present in primary care and do not have signs or symptoms of open-angle glaucoma. Evidence Assessment The USPSTF concludes that the evidence is insufficient to assess the balance of benefits and harms of screening for glaucoma in adults. The benefits and harms of screening for glaucoma in adults are uncertain. More research is needed. Recommendation The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for primary open-angle glaucoma in adults. (I statement).
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glaucoma de Ângulo Aberto / Programas de Rastreamento Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies / Screening_studies / Systematic_reviews Limite: Adult / Humans País como assunto: America do norte Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glaucoma de Ângulo Aberto / Programas de Rastreamento Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies / Screening_studies / Systematic_reviews Limite: Adult / Humans País como assunto: America do norte Idioma: En Ano de publicação: 2022 Tipo de documento: Article